Article
FeNO as a Treatable Trait in Chronic Cough: Insights from the PROCOUGH Study.
Lung - 15 Jul 2026
Wahab Mustafaa, Kum Elena, Diab Nermin, Brister Danica, Oliveira Ana, Hassan Wafa, Beaudin Sue, Stevens Catie, Wattie Jennifer, Wiltshire Lesley, Howie Karen, Killian Kieran, Sehmi Roma, Gauvreau Gail M, O'Byrne Paul M, Satia Imran
Abstract excerpt
PURPOSE: Type 2 (T2) inflammatory biomarkers are established therapeutic targets in asthma and non-asthmatic eosinophilic bronchitis (NAEB), but their relevance in chronic cough remains unclear. Therefore, the objective of our study was to evaluate the relationship between T2 biomarkers and cough outcomes, and to determine their ability to predict treatment response and cough control. METHODS: This post-hoc...
Topics
Join the communities discussing this publication.
